Wise to Wait: Abortion Pill
Wise to Wait
The Canterbury District Health Board is wise to hesitate before making the abortion pill RU486 (mifepristone) available at the abortion facility at Lyndhurst Hospital, because of the drug’s dangers, says Mrs Josephine Reeves, President of Voice for Life.
“RU486 has been responsible for at least 5 deaths in the United States, and its use is now under investigation by the Food and Drug Administration in the USA. Any drug which causes a woman to abort in the early stages of pregnancy must cause a grave shock to the woman’s system.”
Instead of pushing for wider choices for abortion procedures, more attention should be given to the negative aspects of abortion, says Mrs Reeves. “We should be giving more heed to the proven increased risk of breast cancer following first abortions, and the proven effects of depression and mental illness. We should be worrying about the ageing of our population due to negative birth rate. And finally we might spare a thought for the 18000 babies each year who never see the light of day.”
New Zealand Kindergartens: 100-Years On - Investing In Teacher-Led, Quality Early Childhood Education Is Investing In Aotearoa’s Future
Dry July: Thousands Set To Go Alcohol Free This July As Cancer Diagnoses Continue To Rise Across Aotearoa
New Zealand College of Midwives: Celebrating Midwives Across Aotearoa This International Day Of The Midwife
PPTA Te Wehengarua: Building The Secondary Curriculum On Broken Drafts Is A Serious Risk
Whanganui Regional Museum: Whanganui Makers Bring Textile Traditions To Life During Symposium Weekend
Palmerston North Hospital Foundation: Fundraising For Publicly-Owned Surgical Robot Hits $2 Million Milestone In Less Than Three Months